@inproceedings{inproceedings, title  = {{AZD2171, an oral, highly potent VEGFR signaling inhibitor, in combination with gefitinib or paclitaxel: Results of a study in an orthotopic human lung adenocarcinoma model.}},

 url = {{}},

 year = {{2005}},

 month = {{1}},

 author = {{Wu WJ and Fujitaka K and Mandal J and Imagumbai T and Ryan A and Jurgensmeier J and Fidler IJ and O'Reilly MS and Herbst RS}},

 volume = {{11}},

 journal = {{CLINICAL CANCER RESEARCH}},

 issue = {{24}},

 pages = {{9034S-9034S}},

 note = {{Accessed on 2024/12/26}}}